Preference for Subcutaneously Administered Low-Dose Glucagon Versus Orally Administered Glucose for Treatment of Mild Hypoglycemia: A Prospective Survey Study

INTRODUCTION: Intensive insulin treatment for type 1 diabetes is associated with high risk of mild hypoglycemia. Mild hypoglycemia is usually treated orally with glucose, which may contribute to weight gain. Subcutaneous injection of low-dose glucagon may be a new treatment option for some occasions...

Descripción completa

Detalles Bibliográficos
Autores principales: Tetzschner, Rikke, Ranjan, Ajenthen G., Schmidt, Signe, Nørgaard, Kirsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848710/
https://www.ncbi.nlm.nih.gov/pubmed/31552599
http://dx.doi.org/10.1007/s13300-019-00696-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848710/
https://www.ncbi.nlm.nih.gov/pubmed/31552599
http://dx.doi.org/10.1007/s13300-019-00696-x

Ejemplares similares